A novel molecular variant of the neutrophil-activating peptide NAP-2 with enhanced biological activity is truncated at the C-terminus: Identification by antibodies with defined epitope specificity
- 1 August 1993
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 30 (11) , 979-991
- https://doi.org/10.1016/0161-5890(93)90123-s
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide IIICytokine, 1991
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991
- Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.The Journal of Experimental Medicine, 1989
- Connective tissue activation XXXIII. Biologically active cleavage products of CTAP-III from human plateletsBiochemical and Biophysical Research Communications, 1989
- Purification of granulocyte chemotactic peptide/interleukin‐8 reveals N‐terminal sequence heterogeneity similar to that of β‐thromboglobulinEuropean Journal of Biochemistry, 1989
- A novel cleavage product of β-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophilsBiochemical and Biophysical Research Communications, 1989
- Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP)Biochemical and Biophysical Research Communications, 1988
- Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).The Journal of Experimental Medicine, 1987
- Complete covalent structure of human .beta.-thromboglobulinBiochemistry, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970